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ABSTRACT
Objective: The relationship between brain tumors and cognitive deficits is well established 
in the literature. However, studies investigating the cognitive status in low and high-grade 
gliomas patients are scarce, particularly in patients with average or lower educational level. 
This study aimed at investigating the cognitive functioning in a sample of patients with 
low and high-grade gliomas before surgical intervention. Method: The low-grade (G1, 
n=19) and high-grade glioma (G2, n=8) patients underwent a detailed neuropsychological 
assessment of memory, executive functions, visuo-perceptive and visuo-spatial abilities, 
intellectual level and language. Results: There was a significant impairment on verbal 
and visual episodic memory, executive functions including mental flexibility, nominal 
and categorical verbal fluency and speed of information processing in G2. G1 showed 
only specific deficits on verbal and visual memory recall, mental flexibility and processing 
speed. Conclusion: These findings demonstrated different levels of impairments in the 
executive and memory domains in patients with low and high grade gliomas. 
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RESUMO
Objetivo: A associação entre tumores cerebrais e déficits cognitivos é bem estabelecida 
na literatura. No entanto, estudos sobre a cognição de pacientes com gliomas de baixo e 
alto grau são escassos, especialmente, em sujeitos com baixa escolaridade. Este estudo 
investigou o funcionamento cognitivo de uma amostra de pacientes com gliomas de 
baixo e alto grau antes da intervenção cirúrgica. Método: Os pacientes com glioma de 
baixo grau (G1, n=19) e alto grau (G2, n=8) foram avaliados quanto à memória, funções 
executivas, habilidades visuo-perceptivas e visuo-espaciais, nível intelectual e linguagem. 
Resultados: Houve prejuízo significativo em G2 na memória episódica verbal e visual, 
funções executivas incluindo flexibilidade mental, fluência verbal nominal e categórica e 
velocidade de processamento de informações. G1 demonstrou apenas déficits específicos 
de evocação verbal e visual, flexibilidade mental e velocidade de processamento. 
Conclusão: Estes achados demonstraram níveis diferenciados de comprometimento nos 
domínios executivos e mnésticos de pacientes com gliomas de baixo e alto grau.
Palavras-chave: gliomas de alto grau, gliomas de baixo grau, tumores cerebrais, funções 
cognitivas.
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The gliomas are the most frequent primary tumors 
of the central nervous system (CNS). They originate 
from the neuroglial, astrocyte, oligodendrogliocyte, ep-
endymal and microglial cells, which are responsible for 
the maintenance and protection of the neuron. The ol-
igodendrogliomas, astrocytomas, mixed gliomas (com-
bined oligodendroglial and astrocytic elements) and ep-
endymomas represent 60% of all brain tumors1,2.
The astrocytomas are derived from the astrocytes. 
They correspond to 30% of the gliomas and are more 
frequent in males (World Health Organization - WHO). 
They are also described according to the degree of malig-
nancy as low-grade or high-grade3. The low-grade astro-
cytomas are of grade I and II4 and the patients with this 
type of tumor have an average survival of more than 10 
years for grade I and from 8 to 10 years for grade II5. They 
are typically seen in adults with age under 40. However, 
the low-grade astrocytomas are infiltrative and present 
a potential for malignancy6. The anaplastic astrocy-
toma (grade III) and the glioblastoma (grade IV) are the 
high-grade astrocytomas4. The multiform glioblastomas 
(MGB) correspond to 55% of the intracranial gliomas and 
are considered the most anaplastic form of the primary 
neoplasms of the CNS. It can result from a malignant 
transformation of another glioma or it can be an MGB 
from the beginning. This is the most aggressive subtype 
of glioma3 with a survival rate between 8 and 18 months7. 
The oligodendrogliomas represent 5% of the gliomas and 
are usually present in the frontal lobes4. In other studies, 
however, it represented 10% of cases3 or 25 to 33% of gli-
omas8. They can be seen at any age, although the initial 
diagnosis has two peaks of incidence: at 6 to 12 years 
and at 35 to 44 years. This tumor is also more frequent 
in males and more than 90% of them originate in the su-
pratentorial white matter including the frontal lobes and 
less than 10% begin in the posterior fossa9. There are 
two category grades, namely grade II and III, neverthe-
less the commonest tumor is the anaplastic or grade III4. 
In general, the cognitive alterations resulted from the 
neoplastic processes are related to the compression, dis-
placement, destruction or isquemia of intracranial struc-
tures, as well as, associated cerebral edema. These cogni-
tive deficits are present at the moment of the diagnosis in 
50 to 80% of pacients10. It’s impact on daily life activities 
(DLA) and quality of life of patients are recognized espe-
cially in patients with high-grade malignant gliomas with 
a relatively short survival11. On the other hand, studies in 
patients with low-grade glioma indicate that this type of 
brain tumor also produces cognitive deficits12. 
The majority of the studies showed that cognitive 
functioning in patients with glioma can be affected by 
the tumor, the epilepsy related to the tumor, the surgical 
treatment, the radiotherapy, the chemotherapy, antiep-
ileptic or corticosteroid drugs and factors related to the 
patient, including age7,9-12. 
Memory is frequently impaired, particularly in 
patients with tumors in the frontal and temporal lobes 
and in the region of the thalamus13. Executive func-
tioning is usually impaired in patients with low-grade 
gliomas in the frontal lobes. In this context, the assess-
ment of the intellectual abilities is important since high 
intellectual level subjects present a greater cognitive re-
serve and adaptive skills, which allow for compensa-
tion of the cognitive symptoms at the beginning of the 
tumor development14. Klein et al.15 showed that individ-
uals with low-grade glioma also present reduced pro-
cessing information speed. Hahn et al.16 evaluated the 
cognitive functioning of patients with high-grade glioma 
and demonstrated that the subjects with tumors in the 
left hemisphere showed more memory problems, im-
paired verbal fluency and verbal learning. These cogni-
tive alterations also affect patients DLA, occupational 
status and quality of life17. 
Systematic and detailed assessment of cognitive func-
tioning in these patients is of relevance allowing for an 
early detection of these changes and therapeutic inter-
ventions, which can minimize the worsening of these 
symptoms. However, studies in the literature on the neu-
ropsychological alterations in patients with high and 
low-grade gliomas and low educational level are scarce. 
The aim of the current study was to investigate and com-
pare the performance of patients with diagnoses of high 
and low-grade glioma before surgical intervention. 
METHOD
Subjects
The participants were recruited from the Neuro-On-
cology Group of the Hospital das Clinicas, FMUSP. They 
had diagnoses of astrocytomas, oligodendroglioma and 
multiform gliobastoma (MGB) and were allocated into 
two groups (Table 1): patients with low-grade glioma or 
G1 (n=19) and with high-grade glioma or G2 (n=8). Neu-
roimaging and histopathological examinations confirmed 
the diagnoses. 
All patients were assessed before the surgical pro-
cedure and they had no previous history of cerebral tu-
mors, use of medication for psychiatric symptoms or 
history of psychosis, depression or alcohol abuse. They 
were selected at the multidisciplinary meeting day and 
assessed by neuropsychologists on the same day of their 
medical appointment as outpatients. Illiterate sub-
jects were excluded due to the need of reading of some 
instruments. 
The study was approved by the hospital ethical com-
mittee board (CAPPESQ nº 086/06) and before entering 
the study all patients signed an informed consent form.
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The testes included in the current study and the func-
tions assessed by them are described on Table 2.
RESULTS
Initially, the two groups of patients (G1 and G2) were 
compared in terms of age and education with Anova tests 
using the SPSS v.16 program. There were no significant 
differences between the two groups on these variables 
(age: F=3.63, P=0.068; schooling: F=0.38, P=0.546). The 
average age for G2 was 54.63 years (SD=7.95) and 46.0 
years (SD=11.64) for G1. The average years of education 
for G2 was 7.0 (SD=2.83) and 7.94 years (SD=3.30) for G1. 
Subsequently, the results of each group were analyzed 
according to the percentiles obtained by the patients and 
the norms of the tests taking into account the age and 
education of the subjects (Table 3). In general, the two 
groups of patients with gliomas (G1 and G2), particularly 
G2, were impaired on more than two cognitive domains 
including nominal and categorical verbal fluency (exec-
utive function), episodic visual recognition memory and 
episodic immediate verbal recall. G1 was impaired on im-
mediate and delayed verbal memory recall as well as on 
the nominal verbal fluency and processing speed (Figure). 
Both groups of patients fell into the below average 
range on testes of estimated general intelligence (G1: 
IQ=84.84, SD=15.63; and G2: IQ=84.25 SD=16.43). The 
two groups did not show significant differences in terms 
of total IQ (F=0.08, P=0.93).
Next, the results of each group were described con-
sidering the injury location.
Results for G1 
Out of the five patients with left frontal lesions, 3 
(60%) were in the impaired range on tests of immediate 
Table 1. Distribution of the sample according to area and hemi-
sphere of the lesion.
Type Hemisphere
Gliomas
High 
grade 
(n=8)
Low 
grade 
(n=19)
Frontal Left 1 5
Right 3 3
Temporal Left 0 2
Right 1 3
Occipital Left 0 1
Right 0 1
Fronto-temporal Left 0 1
Right 0 1
Fronto-parietal Left 0 1
Fronto-insular Left 0 1
Fronto-temporo-insular Left 0 1
Temporo-parietal Left 1 0
Temporo-occipital Right 1 0
Temporo-parieto-occipital Right 1 0
Intraventricular 0 1
Table 2. Tests and neuropsychological functions.
Neuropsychological functions Tests
Intellectual functions Vocabulary and Matrix Reasoning (WASI-III)18
Memory functions
   Short-term memory Digits (WAIS-III)21
   Verbal episodic memory (immediate and delayed recall and recognition) Hopkins Verbal Learning Test - R (HVLT-R)19
   Visuo-spatial episodic memory (immediate and delayed recall and recognition) Brief Visual Memory Test - R (BVMT-R)20
Visuo-perceptual and visuo-spacial functions
   Fragmented letters VOSP22,23
   Discrimination of points 
Executive functions
   Nominal verbal fluency FAS-Test22,23
   Categorical verbal fluency Category Fluency - Animals22,23
   Mental flexibility WCST26
Processing speed Symbol Digit Modality Test - Oral Version25
Naming Boston NamingTest22-24
verbal recall and information processing speed, 2 (40%) 
on mental flexibility and nominal verbal fluency and 1 
(20%) on categorical verbal fluency. One subject was in 
the borderline range on immediate verbal recall, pro-
cessing speed, nominal verbal fluency, as well as in cate-
gorical verbal fluency. 
Out of the three patients with right frontal lesions, 
2 (66.6%) were in the impaired range on the tests of im-
mediate verbal and visual memory recall and 1 (33.3%) 
Arq Neuropsiquiatr 2011;69(4)
 599
Gliomas: cognitive impairments
Miotto et al.
on mental flexibility and nominal and categorical verbal 
fluency. All of these patients were in the impaired range 
on tests of information processing speed. 
The two individuals with the single lesion on the 
left temporal lobe were impaired on tests of immediate 
verbal recall and processing speed. 
Out of the three patients with a single lesion on the 
right temporal lobe, 2 (66.6%) were impaired on imme-
diate visual and verbal recall and information processing 
speed. One subject (33.3%) was impaired only on pro-
cessing speed. 
The patient with the lesion in the left occipital lobe 
was impaired on immediate verbal recall and informa-
tion processing speed. The subject with the lesion in the 
right occipital lobe fell in the low average range on pro-
cessing speed and nominal verbal fluency. 
The patient with left frontal-temporal lesion was im-
paired on immediate and delayed verbal memory recall, 
nominal and categorical verbal fluency. 
In the only case of intraventricular lesion, the patient 
was impaired on immediate verbal recall and processing 
speed.
Results for G2 
The only case of frontal lobe lesion in the left hemi-
sphere was impaired on mental flexibility, immediate 
verbal recall and nominal verbal fluency. Out of the 3 
subjects with frontal lesion on the right, 2 (66.6%) were 
impaired on immediate visual and verbal memory and 1 
(33.3%) on mental flexibility. 
In the only right temporal lesion case, the individual 
was in the deficient range on immediate and delayed vi-
Table 3. Results of the neuropsychological tests administered expressed as average and standard deviation and percentiles for the patients 
with high grade (n=8) and low grade (n=19) glioma.
Neuropsychological tests 
High grade glioma (G2) Low grade glioma (G1)
Average (SD) Percentile average (SD) Average (SD) Percentile average (SD)
WASI Vocabulary 34.6 (15.8) 15.8 (20.7) 38.6 (16.2) 23.8 (26.9)
Matrix Reasoning 13.4 (8.62) 35.95 (39.06) 13.4 (6.09) 30.13 (33.75)
IQ estimated 84.25 (16.43) 22.5 (28.99) 84.84 (15.63) 22.3 (23.73)
Digits Direct Order 5.43 (1.27) 28.0 (13.5) 6.74 (2.13) 48.0 (27.5)
Inverse Order 3.14 (1.07) 4.63 (2.19)
HVLT-R Immediate Recall 14.5 (5.68) 4.88 (10.6) 18.1 (6.61) 10.1 (20.9)
Delayed Recall 4.5 (3.78) 12.25 (23.49) 5.47 (3.45) 13.74 (23.11)
Recognition 10.0 (2.27) 40.9 (28.1) 9.16 (2.63) 30.5 (32.0)
BVMT-R Immediate Recall 14.5 (10.54) 13.63 (26.69) 17.26 (8.12) 15.89 (26.33)
Delayed Recall 5.25 (4.2) 15.75 (38.8) 5.84 (3.55) 16.0 (28.44)
Recognition 4.95 (1.08) 10.25 (7.23) 5.13 (1.13) 47.8 (3.54)
VOSP Fragmented Letters 15.75 (6.78) 29.38 (38.61) 17.95 (3.27) 25.32 (25.53)
Discrimination of Points 18.63 (3.89) 64.88 (26.27) 18.68 (2.38) 42.95 (24.62)
FAS (Nominal verbal fluency) 15.0 (5.81) 9.75 (8.21) 18.89 (10.52) 9.16 (7.65)
Categorical verbal fluency (Animals) 9.33 (2.94) 5.67 (4.93) 11.1 (4.79) 18.37 (24.21)
WCST categories 2.98 (2.19) 7.0 (10.43) 3.19 (2.01) 10.0 (9.29)
Symbol Digit (time) 28.75 (21.25) 21.5 (26.41) 22.0 (8.35) 4.11 (5.71)
Boston Naming Test 42.13 (15.72) 54.4 (37.4) 46.83 (11.84) 52.6 (31.1)
*Percentiles obtained according to the normative data for each test.
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sual and verbal recall. In the only case of temporal-oc-
cipital lesion on the right, the subject was in the deficient 
range on immediate visual and verbal memory recall and 
visual recognition. In the only incident of parietal-tem-
poral-occipital lesion on the right, the individual was mod-
erately impaired on immediate visual and verbal recall. 
DISCUSSION
This study aimed to investigate the cognitive func-
tioning of patients with low and high-grade gliomas 
before surgery. The main results demonstrated an im-
paired performance in G1 and G2 on tests of executive 
functions, especially of mental flexibility, nominal and 
categorical verbal fluency, as well as on immediate and 
delayed verbal and visual memory recall. These find-
ings corroborate with some studies in the literature 
showing the involvement of the executive and memory 
domains specifically in patients with frontal-temporal 
lesions13,14,27-30. 
The majority of the high-grade glioma patients (88%) 
showed impairments on speed of information pro-
cessing, executive functions, verbal and visual memory 
independently of the lesion location. This could pos-
sible be explained by the fact that most tumor lesions 
in this group involved subcortical or white matter re-
gions. There is evidence that these regions are directly 
associated with such functions5,7,10,14. Also in this group, 
patients with left hemisphere lesions were impaired on 
verbal immediate memory recall. These results are in 
line with studies demonstrating memory deficits in pa-
tients with injuries in the left hemisphere14,16,28-30. The pa-
tients with right hemisphere lesions also had immediate 
verbal memory recall deficits. It is possible that the dif-
fuse growth of the tumor cells could have infiltrated the 
normal cerebral tissue invading areas of the left hemi-
sphere. There is also some evidence showing that im-
pairment of executive function can alter verbal memory 
and learning14,27-30. The deficits of visual recognition epi-
sodic memory were found in patients with tumors in the 
right hemisphere and these findings have already been 
shown in other patients with right side lesions5,7,14,27,29,30. 
In patients with low-grade gliomas, those with left 
hemisphere tumors were impaired on immediate and 
delayed verbal memory recall. Those with intraventric-
ular and posterior fossa tumors (occipital region on the 
left) were impaired on immediate verbal memory recall 
and executive functions particularly speed of informa-
tion processing. Here again, this could also be associated 
with the involvement of subcortical and white matter 
regions14,29. 
Some studies on patients with gliomas reported that 
the educational and intellectual levels are relevant to the 
presence of cognitive deficits. Individuals with high in-
tellectual level can demonstrate better adaptive skills 
or cognitive reserve which allows to compensate for 
their cognitive impairments and postpone their appear-
ance7,14. Since most of the patients in the current study 
had less than eight years of education, this perhaps ex-
plains the largest number of cognitive alterations in pa-
tients with either low or high-grade gliomas. Nonethe-
less, patients with high-grade gliomas performed at the 
impaired range on more functions than those with low-
grade gliomas including, executive functions and epi-
sodic memory. 
These findings demonstrate that a comprehensive 
cognitive assessment is relevant to the identification of 
the presence and level of extent of cognitive deficits in 
patients with low and high-grade gliomas prior to the 
surgical treatment.
One of the limitations of the present study was the 
small sample. Future studies with larger populations, 
range of educational level and comparisons between the 
pre- and post-operative cognitive status are necessary. 
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